Financial toxicity in hematological malignancies: a systematic review.

ABSTRACT: Hematologic malignancy outcomes have remarkably improved in the past decade with further advancement expected in future years. However, the detrimental effects of financial toxicity (FT) on patients with hematologic malignancies, because of both diagnoses and subsequent treatments, have not been studied comprehensively. We performed a systematic review of all studies reporting FT as a primary or secondary outcome among adult or pediatric patients with hematological malignancies. A total of 55 studies met the inclusion criteria for analysis. Across studies, 20-50% of patients reported some form of FT, including loss of work productivity, food and transportation costs, and depletion of savings. Younger age, lower-income level, unemployment, and rural residence were the most commonly identifi

SUBMITTER: Ouchveridze E 

PROVIDER: S-EPMC9033803 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature